CollPlant Biotechnologies (CLGN) Q1 2025 Earnings
CLGN·Reported May 28, 2025·Before market open
CollPlant Biotechnologies reported Q1 2025 revenue of $2.1M, missed analyst consensus of $8.9M by $6.9M. Diluted EPS came in at $-0.13, beat the $-0.37 consensus by $0.24.
Revenue
$2.1Mmissed by $6.9M
Consensus: $8.9MDiluted EPS
$-0.13beat by $0.24
Consensus: $-0.37
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2025 Earnings FAQ
Common questions about CollPlant Biotechnologies's Q1 2025 earnings report.
CollPlant Biotechnologies (CLGN) reported Q1 2025 earnings on May 28, 2025 before market open.
CollPlant Biotechnologies reported revenue of $2.1M and diluted EPS of $-0.13 for Q1 2025.
Revenue missed the consensus estimate of $8.9M by $6.9M. EPS beat the consensus estimate of $-0.37 by $0.24.